American BioDental acquires Omnigene Diagnostics:
This article was originally published in Clinica
Executive Summary
American BioDental has purchased Omnigene Diagnostics. The acquisition is part of a major restructuring at American BioDental and will be the first of many acquisitions in the dentistry and related fields, says the company. American BioDental, the parent company of Minimatic Implant Technology, obtained $1 million capital through two investment companies based in the Bahamas and Abu Dabi to part-finance the deal. Omnigene develops DNA probe-based tests for periodontal disease diagnosis. MIT develops and markets precision components for dental implants.